Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and even increase muscle and lean mass- Élancé Therapeutics ...

With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it has earned a ...

“Weight loss of 13.7% falls short of our 15+% bar that would have suggested amylin offers a differentiated profile vs GLP-1 in this population, with result in-line with GLP-1s that show 30 ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...

Rhumbline Advisers lifted its holdings in shares of Zura Bio Limited (NASDAQ:ZURA – Free Report) by 37.3% during the 4th quarter, according to its most recent 13F filing with the Securities and ...

The safety profile of CagriSema was consistent with the GLP-1 receptor agonist class, with the most common adverse events being gastrointestinal issues that were mostly mild to moderate and decreased ...

The American healthcare system is often a maze of insurance policies, long wait times, and frustrating bureaucracies. But what if there was a better way—one that put patients first, eliminated co-pays ...

Etanercept (Enbrel ®) is an injectable fusion protein that competitively inhibits the pro-inflammatory cytokine TNF-α. It is approved for use in rheumatoid arthritis, juvenile rheumatoid ...